TENEX
GUANFACINE HYDROCHLORIDE
Approval overview TENEX is listed in Drugs@FDA under application 019032 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient GUANFACINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PROMIUS PHARMA Submission history Latest submission status date: 2013-07-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview TENEX is listed in Drugs@FDA under application 019032 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient GUANFACINE HYDROCHLORIDE Form and strength TABLET;ORAL - EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PROMIUS PHARMA Submission history Latest submission status date: 2013-07-03 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.